BioVitrum
Biovitrum is the producer and the distributor of the medical diagnostic equipment and supplies.
History
2020: Construction plans of a production and warehouse complex in the Leningrad Region for 500 million rubles
On September 29, 2020 it became known that the Biovitrum company which is releasing medical products will construct in the industrial zone Gorelovo (Leningrad Region) a production and warehouse complex. Thanks to transfer of capacities to the Leningrad Region the investor expects to increase the turnover to more than 1 billion rubles that is twice higher than the current indicators. Is going to open this Biovitrum complex in January, 2023.
Plans for construction of a production and warehouse complex in the Leningrad Region to Kommersant were announced by the CEO of Biovitrum LLC Vladimir Tsimberg. According to him, the company is in process of purchase of the land plot of 2.5 hectares in the industrial zone Gorelovo where capacities will be located. In the territory of a complex will set lines of production of the laboratory equipment from metal, supplies and reagents for diagnosis of oncological diseases, microbiological environments. Besides, the laboratory of research and development, warehouse and administration rooms will be placed here. Investments into the project will make 500 million rubles of own and borrowed funds. Contributions to the regional budget will make according to preliminary estimates not less than 70 million rubles a year.[1]
One of the moving reasons — need of expansion of production areas, mister Tsimberg explains. for September, 2020 the enterprise rents 5 thousand sq.m in the territory of the former plant "Priboy" in St. Petersburg. The project in the Leningrad Region will allow to increase the area to 15 thousand sq.m. Expansion of a laboratory complex and engineering group will give the chance to make more investments in creation of own products for diagnostics in the field of oncology and bacteriological researches.
Plans Biovitrum for construction of a production and warehouse complex are justified as the import substitution program is sold in the market of medical products, the development director of RNC Pharma company Nikolay Bespalov explains. Besides in the conditions of devaluation of ruble of the price of import products grow that increases attractiveness of domestic goods, he notes[2].
2018: Plans for opening of office in Europe
On June 1, 2018 it became known that the Biovitrum company is going to open the representation in Europe. With opening of the European office the company expects to increase a share of the paraffin delivered abroad in the total amount of the made products from 5% to 20% in two years.
It is, in particular, about deliveries of the special paraffin environment for histologic filling of Histomix which is applied in laboratory diagnostics. Biovitrum already delivers this product in clinics of Kazakhstan and Belarus, and in 2017-2018 began to execute its export deliveries to Uzbekistan, Latvia, Serbia, China. The first deliveries are planned to Germany and Finland.
As the CEO of Biovitrum Vladimir Tsimberg explained, the office in Europe will help the company to avoid medical products of administrative barriers, characteristic of the Russian market, and excessive "overregulation". According to him, costs will be removed, the convenience of a company performance with clients and foreign suppliers will increase, there will be no excess document flow.
 | We are in Russia under the influence of a set of regulatory services which occasionally clash among themselves. It is a web in which we fight as a fly on light — Tsimberg noted. |  |
Besides, the European representation will provide advantages in logistics and at SE-certification (on compliance to requirements of the European Union) and at the same time will save the company from risks at change of a political environment, the head of Biovitrum is convinced.
The exact place for organization of representation in the company was not called yet. However it is known that as one of such places the management Biovitrum considers Germany.
According to Tsimberg, in the future the European office can be also engaged in research and development (Research and Development), conduct which in Russia difficult for a number of reasons. Among them the head of Biovitrum called logistics, import of complex reagents and component parts, rise in price several times of such deliveries that he, in turn, attracts impossibility or difficulties for personnel in implementation of the developments. Besides, there is a request and for localization of production in other countries, such opportunity is not excluded, he concluded.[3]
2017: Expansion of a warehouse in St. Petersburg
Moving of a warehouse of Biovitrum company is an optimization of internal logistic processes, and expansion of warehouse which big accumulative capability will allow to react quicker to requests and to implement orders.
2016: Start of rates of additional medical education for laboratory assistants-histologists
Программы of a rate are based on training in modern methods and standards of work in histologic laboratory. Two bases of programs: narrow specialization and practical orientation.
2015: Turnover exceeded 2 billion rubles.
Turnover of Biovitrum LLC for 2015 made 2 billion rubles.
2014
Release of a HSS of Histoviewer
B of 2014 Biovitrum provided Histoviewer - a unique hardware-software complex (HSS) which transfers process of pathoanatomical researches, diagnostics and training to the advanced level modern smart technology of visualization and the analysis of histologic medicine.
At the time of design of a HSS of HistoViewer the question of development of the convenient Russified program which would provide necessary morphometric with functionality, both the pathologist, and the teacher of specialized universities was particularly acute. Each producer of scanners (Leica, 3DHistech, Hamamatsu, Aperio) created the closed software for viewing the digitized images in English which is not capable to work with files of competitive formats. Thus, within one purpose and identical or close characteristics several file formats were created that complicated to users work with them. Not one of the applications existing at that time was not adapted for touch screens.
Виктор Bovin, HSS developer: "For this reason the decision on development of a HSS of HistoViewer which would provide convenient viewing on the big touch monitor of images of medicines which are scanned on scanners of different producers was made. Russian and a convenient intuitive morphometry became additional important benefits".
Start of the Histoscan.com portal
In 2014 Biovitrum submitted Histoscan.com - the first Russian portal for Digital Pathology. The Russian society of pathologists highly appreciated opportunities and quality of the portal and recommends its use for development of domestic telemedicine.
New division in structure of the company – Life Science
In 2014 new structural unit - Life Science integrated two divisions: molecular and cellular biology and microscopy. Internal reorganization was carried out for the purpose of increase in qualitative level of training of projects in a scientific segment.
Upgrade of workshop of metal production of a full stroke
In 2014 the Biovitrum company upgraded the production capacities. Modern high technology production specializes in processing and production of metal parts of any complexity. Production of a full stroke, since execution of drawings and creation of 3D models is organized, finishing with accomplishment of complex design works.
====A new line of dyes for histology the Premium
In 2014 Biovitrum developed a new line of histologic dyes of a self-produced Premium class - it is sets and solutions for carrying out ad hoc methods of coloring. All products are certified and there takes place strict quality control in laboratory.
By this time the company is issued more than 1000 names of goods. The line constantly extends.
Opening of office in Vladivostok and representations in Yekaterinburg and Ufa
B territorial presence of Biovitrum company extended 2014 on two strategic and significant the region of Russia at once – the Far East (Vladivostok) and the Ural (Yekaterinburg) federal districts. Also the company strengthened the positions in the Volga Federal District (Ufa).
2012
Self-produced opening of the microbiological Sredoff environments
In 2012 self-produced discovery of microbiological nutrient mediums for selection and identification of the microorganisms Sredoff made from the English components took place.
2011: Opening of representation in Kazan
B 2011 in the capital of the Republic of Tatarstan, in Kazan is opened new representative office.
2010
Microbiology - new activity
Новое activity of Mikrobiologiya company began to develop quickly and reached significant market penetration. The main strategy – emphasis on training of specialists and implementation of modern techniques and technologies in work microbiological laboratories.
Opening of department Biovitrum-Siberia
At the end of March, 2010 in Novosibirsk opening of department Biovitrum-Siberia to the address Galushchak St., 2A, office 26 took place.  Earlier activity of Biovitrum company in Siberian Federal District was performed by forces of the regional representative and head office which is in St. Petersburg. Thanks to opening of new office the company is going to optimize costs for logistics and distribution of goods in the region that highly will affect the prices for end customers. Within the program of increase in product availability Biovitrum based on office "Biovitrum-Siberia" the range of tradables of goods begins to be supported constantly.
2008
100% growth of turnover
B of 2008 the Biovitrum company increased turnover by 100%.
The best distributor of the Japanese Sakura
По to results of 2008 the Sakura company (Japan) highly noted achievements Biovitrum in an issue of distribution of products. The award was presented to the CEO Biovitrum Vladimir Tsimberg.
Opening of branch in Kazakhstan
Расширение of geography of presence of Biovitrum company – opening of offices in Kazakhstan will allow to cover new the market, to be closer to clients, to react quickly to requirements and to implement projects of any complexity.
2007: Intensive growth of turnover of the company
In 2007 intensive development of the company leads to upgrade of internal processes and formation of new customer relations department. It allows to become Biovitrum more focused on requests of any character and scale. Increase in turnover of supplies leads to expansion of warehouse of the company.
2006
Opening of branch in Moscow
B leads 2006 geographical development of the company to opening of branch in Moscow. The most important and strategically significant region of Russia integrating a large number of the kliniko-diagnostic and scientific institutions concentrated in the district central federalno. Presence in the capital became a priority task of the company.
Start of production of histologic dyes
In 2006 section of production of solutions and dyes for histology in St. Petersburg is started. Expansion and upgrade of chemical production of the company. Advantages of products of the Russian producer: use of the quality raw materials comparable to import products, careful professional quality control of each batch, the verified step-by-step protocols of coloring, fast logistics and low cost value of products.
2005: The customer service is organized
In 2005 the service of service support of the company which part specialists of the high professional grade confirmed with national and international certificates were is created.
2001
Basis of own chemical production
B 2001 Biovitrum opens own production areas in St. Petersburg. Chemical production is based, the ready to application homogenized histologic HISTOMIX paraffin which is produced on the patented technology of the company becomes the first product of medical appointment. In the Russian market supplies for histology under the Biovitrum brand appear.
Distributor's basis Biovitrum
B of 2001 is founded Biovitrum company - the company the distributor of the medicobiological equipment and supplies in Russia from world leading manufacturers. Not only the aspiration to upgrade and reforming of the medicobiological laboratories equipped with the hi-tech equipment but also desire of development of pathoanatomical service in general, its approximations to the international standards became the purpose of the company.
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |